Sam Searcy Talks Accelerating The Clinical Trials Process With Cloud-Based Service Providers

In the last few weeks, the mainstream media ran with stories about Ivermectin, most noticeably referring to it as "horse medicine" or "horse dewormer" while, for some reason, leaving out the fact that Ivermectin is a WHO essential medicine for HUMANS. At the same time, the mainstream media and social media ran with a specific story about Oklahoma hospitals having to turn away gunshot victims because of a surge of people overdosing on Ivermectin. The bombshell story turned out to be false, forcing magazines, like Rolling Stone, to issue a correction, but not before popular news outlets shared it widely on social media, without Big Tech's "disclaimer of shame" for spreading misinformation. Dr. Kory Responds.

An interview with Kelly McKee from Medidata on transforming the patient clinical trial experience.

Join the Conversation! | https://trialsitenews.com/ In the first edition of CATalyst, Shabnam Palesa Mohamed engages Advocate Dipali Ohja (IBA), Dr Pierre Kory (FLCCC), and Dr Tess Lawrie (EBMC) about the Indian Bar Association's decision to issue legal notice on WHO chief scientist, Dr Soumya Swaminathan. The 51 page notice, served 25th of May, claims as its legal basis alleged WHO's 'disinformation and censorship' on the Ivermectin issue. #CATalyst #TrialSiteNews #TrialSiteNewsAfrica #TSNA

We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19. His firm have represented a number of elderly patients who have taken on their respective hospitals who refused to continue to administer doctor prescribed Ivermectin for the treatment Covid-19. This episode does not discuss the efficacy of the drug in relation to the virus, but rather, the legal fight surrounding it. Watch the video to hear the whole story! Join The Conversation, Visit us at: www.trialsitenews.com Check out the Law Office Of Ralph C. Lorigo: https://www.lorigo.com/

Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and turns of the legality issues of the drug, to a campaign to bring awareness through-out the country and beyond. Petition Link: https://www.change.org/p/president-cyril-ramaphosa-south-africa-has-a-right-to-ivermectin

We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in autoimmune diseases that effect the musculoskeletal system, such as rheumatism, arthritis, and other disorders of the joints, muscles and ligaments. Dr. Kedar's Website: https://www.ruralamericaandcovid19.com/ Google podcasts: https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8zZTM0NjM1Yy9wb2RjYXN0L3Jzcw== Spotify: https://open.spotify.com/show/41OxseQXTDxL8Zbru2YUNg Apple podcasts: https://podcasts.apple.com/us/podcast/rural-america-and-covid-19/id1552461945

Today we’ll be touching on a tough subject, Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord.   Essentially, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause permanent damage or deterioration of the nerves. So, what does this mean? Symptoms range from numbness or weakness one your limbs, electric-shock sensations that occur with certain neck movements, tremors, lack of coordination, and can cause visions like partial, or complete loss of vision. Melanie Rice who herself is suffering from Multiple Sclerosis. She was diagnosed Sept 20 2019 at the Mayo Clinic in Jacksonville Florida. Since then she has uncovered an entire community, or more appropriately, a family of thousands of people struggling with this autoimmune disease. She has become an advocate for MS patients, and so we have brought her on to talk with us about her illness.   Related Links: http://www.wheelchairkamikaze.com/2015/03/national-ms-society-decision-makers.html

We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and study start up. The goal: accelerate each step of the clinical trials process to accelerate the availability of medicines sooner for patients. You can check out Clinistart by clicking here: https://clinistart.com/

We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer.   Dr. Boockvar was one of the neurosurgeons featured on the highly praised Netflix series, Lenox Hill. See link here: https://www.netflix.com/title/80201728   About the Procedure: After standard tumor resection, the patient's own scalp tissue is harvested, rotated and engrafted and used to line the resected tumor cavity. It is our hope that by doing tissue autograft, it will allow to bypass the blood brain barrier so chemotherapeutics and immune cells can better reach the tumor site, improving treatment for GBM patients. The study entitled, "Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Glioblastoma Multiforme," is being led by John Boockvar, MD, the hospital's vice chair, neurosurgery and director of Lenox Hill's Brain Tumor Center. To be eligible for the study, participants must be 18 years of age or older and plan to undergo resection of known or suspected GBM. Press release about the first patient for further background: https://www.northwell.edu/news/lenox-hill-first-to-study-using-tissue-autograft-for-gbm-tumors-in-humans Lenox Hill's neurosurgery department webpage: https://lenoxhill.northwell.edu/neurosurgery Social Media: Instagram: lhh_neurosurgery Twitter: @LenoxNeurosurg Dr. Boockvar, background link: https://www.northwell.edu/about/leadership/john-andrew-boockvar-md Dr. Boockvar's research at the Feinstein Institutes for Medical Research: https://feinstein.northwell.edu/institutes-researchers/our-researchers/john-boockvar-md

An interview with Dr. Gerald Maguire about the Phase 2 Speak Freely Study, which is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, exploratory study in adult subjects with childhood onset fluency disorder. Essentially a study directed at adults with stuttering. About Gerald A Maguire, MD, DFAPA Professor and Chair, Psychiatry and Neuroscience University of California, Riverside School of Medicine Study Link: https://speakfreely.researchstudytrial.com/ World Stuttering Network: http://www.worldstutteringnetwork.net/